03.02.21 -- FDAs COVID-19 PREPP Initiative Summary Report -- Keys For Manufacturers This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CMO service quality across a series of 22 performance attributes specific to outsourced drug substance manufacturing. ISR presents data on 358 service encounters from 123 respondents who hav...

Pete Evans Johnie Young Kate Hammeke Melanie Ziehm Sandra Conway Michael Sherriff

Source: pharmaceuticalonline.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Article Flow Sciences Inc News Today

04.25.23 -- New DSCSA Compliance Blueprint Includes FDA & Industry Input

04.07.23 -- Forming Meaningful Pharma-Academia Partnerships

12.16.22 -- Interest Rates Skew Risk-Return Paradigm For Life Sciences

12.09.22 -- CAPA System Best Practices For GMP Compliance

05.12.22 -- Your New EU IDMP Implementation Strategy

Stay Updated with Latest News

05.06.22 -- FDA's Draft Guidance On CMC For Individualized ASO Therapies

03.02.21 -- FDA's COVID-19 PREPP Initiative Summary Report -- Keys For Manufacturers

Explore More Categories